相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis with Pseudomonas aeruginosa
David E. Geller et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
David E. Geller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
David E. Geller et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2011)
107 In vitro susceptibility of Pseudomonas aeruginosa (PA) does not predict clinical response to aztreonam 75 mg powder and solvent for nebuliser solution (AZLI): a responder analysis in subjects with cystic fibrosis (CF)
T. Pressler et al.
Journal of Cystic Fibrosis (2011)
Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Michael W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Tobramycin Inhalation Powder for P. aeruginosa Infection in Cystic Fibrosis: The EVOLVE Trial
Michael W. Konstan et al.
PEDIATRIC PULMONOLOGY (2011)
Outpatient Treatment of Pseudomonas aeruginosa Bronchial Colonization with Long-term Inhaled Colistin, Tobramycin, or Both in Adults without Cystic Fibrosis
David Berlana et al.
PHARMACOTHERAPY (2011)
Adherence with tobramycin inhaled solution and health care utilization
Becky A. Briesacher et al.
BMC PULMONARY MEDICINE (2011)
Efficiency of the inhalational tobramycin therapy in complex antibacterial therapy of lung exacerbation in cystic fibrosis children with chronic Pseudomonas aeruginosa infection
S.Y. Semykin et al.
Journal of Cystic Fibrosis (2010)
Identifying Barriers to Treatment Adherence and Related Attitudinal Patterns in Adolescents With Cystic Fibrosis
Eric J. Dziuban et al.
PEDIATRIC PULMONOLOGY (2010)
An 18-Month Study of the Safety and Efficacy of Repeated Courses of Inhaled Aztreonam Lysine in Cystic Fibrosis
Christopher M. Oermann et al.
PEDIATRIC PULMONOLOGY (2010)
Inhalable Antibiotic Delivery Using a Dry Powder Co-delivering Recombinant Deoxyribonuclease and Ciprofloxacin for Treatment of Cystic Fibrosis
Yan Yang et al.
PHARMACEUTICAL RESEARCH (2010)
Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment
Giuseppe Valenza et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosis
Michael D Parkins et al.
Expert Review of Respiratory Medicine (2010)
The Detrimental Health Effects of Traffic-related Air Pollution A Role for DNA Methylation?
Tim S. Nawrot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Update in Cystic Fibrosis 2008
Felix Ratjen
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
Mojgan Sabet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Samiya Razvi et al.
CHEST (2009)
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
George Z. Retsch-Bogart et al.
CHEST (2009)
Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S. Islam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Changes in Performance of the Pari eFlow (R) Rapid and Pari LC Plus (TM) during 6 Months Use by CF Patients
Bart L. Rottier et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)
Inhalation Equipment Hygiene: A Belgian National Survey
Gregory Reychler et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
David L. MacLeod et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Patient-reported respiratory symptoms in cystic fibrosis
C. H. Goss et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
High treatment burden in adults with cystic fibrosis: Challenges to disease self-management
Gregory S. Sawicki et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
Aerosol Antibiotics in Cystic Fibrosis
David E. Geller
RESPIRATORY CARE (2009)
A Pipeline of Therapies for Cystic Fibrosis
Melissa A. Ashlock et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Aminoglycoside ototoxicity susceptibility in cystic fibrosis
S. A. Mulrennan et al.
THORAX (2009)
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
Karen S. McCoy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Effects of antibiotics on quorum sensing in pseudomonas aeruginosa
Mette E. Skindersoe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vitro analysis of tobramycin-treated Pseudomonas aeruginosa Biofilms on cystic fibrosis-derived airway epithelial cells
Gregory G. Anderson et al.
INFECTION AND IMMUNITY (2008)
Treatment compliance in children and adults with Cystic Fibrosis
Rosa Patricia Arias Llorente et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Shifting patterns of inhaled antibiotic use in cystic fibrosis
Samuel M. Moskowitz et al.
PEDIATRIC PULMONOLOGY (2008)
Safety assessment of hydroxypropyl methylcellulose as a food ingredient
George A. Burdock
FOOD AND CHEMICAL TOXICOLOGY (2007)
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Exacerbations in cystic fibrosis:: 2 • Prevention
Scott C. Bell et al.
THORAX (2007)
Dry powder inhalation of colistin in cystic fibrosis patients: A single dose pilot study
E. M. Westerman et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Microbial contamination of nebulizers in the home treatment of cystic fibrosis
H. Blau et al.
CHILD CARE HEALTH AND DEVELOPMENT (2007)
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
David E. Geller et al.
PEDIATRIC PULMONOLOGY (2007)
Maintenance azithromycin treatment in pediatric patients with cystic fibrosis - Long-term outcomes related to macrolide resistance and pulmonary function
Gerdien A. Tramper-Stranders et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older
H. A. Tiddens et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2006)
Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis
David Adeboyeku et al.
JOURNAL OF CYSTIC FIBROSIS (2006)
Acute renal failure associated with inhaled tobramycin
Carrie A. Cannella et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Barriers to treatment adherence for children with cystic fibrosis and asthma: What gets in the way?
Avani C. Modi et al.
JOURNAL OF PEDIATRIC PSYCHOLOGY (2006)
A multi-method assessment of treatment adherence for children with cystic fibrosis
Avani C. Modi et al.
JOURNAL OF CYSTIC FIBROSIS (2006)
Inhaled tobramycin-associated hearing loss in an adolescent with renal failure
L Patatanian
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Microbial contamination of nebulization solution and its measures
S Oie et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
A Lambiase et al.
BMC INFECTIOUS DISEASES (2006)
Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients:: Use of high-range etest strips
MI Morosini et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia
D Panidis et al.
CHEST (2005)
Renal and vestibular toxicity due to inhaled tobramycin in a lung transplant recipient
VN Ahya et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
ZH Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease
TD Murphy et al.
PEDIATRIC PULMONOLOGY (2004)
The choice of a compressor for the aerosolisation of tobramycin (TOBI®) with the PARI LC PLUS® reusable nebuliser
AH de Boer et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient-transmission
L Saiman et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2003)
Acute renal failure in cystic fibrosis: Association with inhaled tobramycin therapy
IM Hoffmann et al.
PEDIATRIC PULMONOLOGY (2002)
Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis
NM Walsh et al.
JOURNAL OF PEDIATRICS (2002)
Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis
A Aminimanizani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
ME Hodson et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J Emerson et al.
PEDIATRIC PULMONOLOGY (2002)
Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere® powder
SP Duddu et al.
PHARMACEUTICAL RESEARCH (2002)
Once-daily tobramycin in the treatment of adult patients with cystic fibrosis
A Whitehead et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis
RB Moss
CHEST (2002)
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
MR Kosorok et al.
PEDIATRIC PULMONOLOGY (2001)
Microbiological and immunologic considerations with aerosolized drug delivery
JJ LiPuma
CHEST (2001)
Structural origins of aminoglycoside specificity for prokaryotic ribosomes
SR Lynch et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Technical report: Precautions regarding the use of aerosolized antibiotics
CG Prober et al.
PEDIATRICS (2000)
Pharmacokinetics of tobramycin in adults with cystic fibrosis: Implications for once-daily administration
PM Beringer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs
JS Elborn et al.
THORAX (2000)
分享论文
